Mergers & Acquisitions - OPKO Health


Current filters:

OPKO Health

Popular Filters

OPKO takes 10-fold profit on sale of stake in Sorrento Therapeutics


US drugmaker OPKO Health says it has completed the sale of its stake in Sorrento Therapeutics, a clinical-stage…

FinancialMergers & AcquisitionsOPKO HealthPharmaceuticalSorrento Therapeutics

OPKO Health to buy Lab Arama to expand Latin American presence


Continuing on its acquisitive path, US drugmaker OPKO Health revealed that it has entered into an agreement…

Laboratorio AramaMergers & AcquisitionsOPKO HealthPharmaceuticalSouth America

OPKO makes strategic investment in biotech firm


US pharma and diagnostics firm OPKO Health has agreed to make an undisclosed strategic investment in…

BiotechnologyMergers & AcquisitionsOPKO HealthPharmaceuticalZebra Biologics

OPKO Health to acquire PROLOR Biotech in $480 million stock deal


Continuing on its acquisitive path, US drugmaker OPKO Health (NYSE: OPK) has signed a definitive agreement…

BiotechnologyMergers & AcquisitionsMetabolicsOPKO HealthPharmaceuticalPROLOR Biotech

OPKO Health acquires 10% stake in Russia's Pharmsynthez


USA-based OPKO Health (NYSE: OPK) says it has acquired an approximate 10% stake in OAO Pharmsynthez (MICEX:…

EuropeLicensingMarkets & MarketingMergers & AcquisitionsOPKO HealthPharmaceuticalPharmsynthez

OPKO Health inks deal to acquire Cytochroma and two Ph III products


Privately-held Canadian company Cytochroma says that it has entered into a definitive agreement to be…

AlpharenCytochromaMergers & AcquisitionsNephrology and HepatologyOPKO HealthPharmaceuticalReplidea

OPKO Health to acquire Brazil's Silcon to expand Latin American presence


USA-based OPKO Health (NYSE: OPK) has entered into a definitive agreement to acquire Silcon Comercio,…

Mergers & AcquisitionsOPKO HealthPharmaceuticalSilcon ComercioSouth America

OPKO buys Farmadiet to gain presence in Europe


Making its third acquisition this year, USA-based OPKO Health (NYSE: OPK) said on Friday that it has…

FarmadietMergers & AcquisitionsOPKO HealthPharmaceutical

OPKO Health to acquire 45% stake in Israeli hepatitis B vaccine maker


Miami, USA-based OPKO Health (NYSE: OPK) has entered into a definitive agreement to acquire a 45% stake…

FDS PharmaMergers & AcquisitionsOPKO HealthPharmaceuticalSci-B-VacSciGenVaccines

OPKO Health to acquire Chilean drugmaker; buys cancer tests


Florida, USA-based OPKO Health (NYSE: OPK) had a busy day yesterday, entering into a definitive agreement…

ALS DistribuidoraEuropeMergers & AcquisitionsOPKO HealthPharmaceuticalSouth America

OPKO Health buys API developer


Miami, USA-based OPKO Health (NYSE: OPK), which is controlled by Israeli generics giant Teva Pharmaceutical…

FineTech PharmaceuticalGenericsMergers & AcquisitionsOPKO HealthTeva Pharmaceutical Industries

Back to top